Grants8

Grant Information	Key Details	Eligibility & Funding
Startup Hub: Poland Booster Accelerator Program Startup Hub: Poland Booster Programme: Program Akceleracyjny	The 'Startup Hub: Poland Booster' program aims to support startups and small to medium-sized enterprises (SMEs) through various acceleration paths. Its core objective is to foster business growth, facilitate market entry (both domestic and international), and prepare entities for investment. The program provides equity-free grants as de minimis aid. This grant is SECTOR-AGNOSTIC, with one specific acceleration path dedicated to it. However, the other paths (B2B, VC, Poland Prize, Go-Global) are also not limited to specific industries, focusing on business models, investment readiness, or international expansion regardless of sector. The target recipients are 'startups' (defined as micro or small enterprises operating for no longer than 5 years) and 'micro, small, and medium enterprises' (MSP). The geographic scope covers Poland and extends abroad, with explicit mentions of the Czech Republic and Hungary for international market entry. Key filtering criteria for this grant include the organization's legal classification (startup or MSP), its operational age (for startups), and its strategic interest in acceleration, B2B collaboration, investment, or internationalization. This is a recurring grant program with multiple application rounds.	Funding Up to 400000.00 PLN Deadline Jan. 31, 2026, 10:59 p.m.	Details
Strefa Akceleracji – Acceleration Program for Innovative Startups Strefa Akceleracji Programme: Strefa Akceleracji Program	The 'Strefa Akceleracji' (Acceleration Zone) grant aims to support innovative micro and small startups in Poland by providing specialized knowledge, experience, tools, and financial grants. Its core objective is to accelerate the development and implementation of innovative business ideas, particularly through technology test deployments or expansion into global markets. This grant is primarily for startups, specifically defined as micro and small enterprises. It is SECTOR-SPECIFIC, focusing on areas such as the Marine Industry, Industry 4.0, and Life Science. While the program is based in Poland and managed by Polish entities, the applicant's company location (headquarters) is not a strict barrier for eligibility. The 'Go Global' track explicitly encourages international market expansion, targeting beneficiaries worldwide, though the funding mechanism is managed locally. Key filtering criteria for initial screening include being an innovative micro or small enterprise, generally registered for less than 5 years, and operating within the specified focus sectors. Projects must demonstrate a specific Technology Readiness Level (TRL) or market traction depending on the chosen acceleration path. The grant is recurring, with multiple application rounds planned.	Funding Up to 400000.00 PLN Deadline Jan. 31, 2026, 11:59 p.m.	Details
Startup Spark 3.0 Acceleration Program for Tech Startups Startup Spark 3.0 Programme: Łódzka Specjalna Strefa Ekonomiczna S.A. Acceleration Programs	The 'Startup Spark 3.0' program aims to support micro and small enterprises, specifically startups, in developing new technologies for various business and industrial applications. It also seeks to facilitate their expansion into international markets through a structured acceleration and post-acceleration program. This grant is primarily SECTOR-SPECIFIC in its core technology focus areas (robotics, blockchain, etc.), but it also offers a 'sector-agnostic' track for how those technologies are applied. Target recipients are startups classified as micro and small enterprises. Geographically, applicants must be from Poland. The 'Go Global' track specifically targets expansion into markets such as Israel, the USA, and Spain. Key filtering criteria for initial screening include being a Polish startup, meeting the micro or small enterprise definition, and developing solutions in automatics, robotics, web3, blockchain, sustainable development, or ESG. This is a recurring grant program, being the 'next iteration' of an accelerator initiative run by the Łódź Special Economic Zone since 2017.	Funding Up to 400000.00 PLN Deadline Jan. 31, 2026, 10:59 p.m.	Details
Startup Booster Poland – Scale Up Green – Call for Accelerators FENG.02.28-IP.02-001/25 Programme: Fundusze Europejskie dla Nowoczesnej Gospodarki	This grant, 'Startup Booster Poland – Scale Up Green', aims to select and fund organizations (accelerators) that will run professional acceleration programs. The core objective is to support innovative startups developing solutions for the Circular Economy (known as GOZ in Polish, which stands for Gospodarka o Obiegu Zamkniętym). These programs must facilitate the piloting and potential implementation of startup solutions within large enterprises (called 'Technology Recipients') to help these large businesses transition towards a circular economy model. A crucial part of the projects is also to spread knowledge about the Circular Economy among large enterprises in Poland. This is a SECTOR-SPECIFIC grant, focused entirely on the Circular Economy and related green technologies. Target Recipients: The funding is for entities operating in support of innovation and economic development. These include, but are not limited to, technology transfer centers, innovation centers, technological incubators, academic entrepreneurship incubators, and technology parks. The grant directly benefits these accelerators, who in turn support startups and large enterprises. Geographic Scope: Projects must be implemented in Poland. Key Filtering Criteria for Initial Screening: - Your organization must be an established entity supporting innovation and registered in Poland. - You must have proven experience in running acceleration programs, specifically those involving Circular Economy (GOZ) solutions and collaboration with potential technology recipients. - Your proposed acceleration program must align with Poland's National Smart Specialization (KIS 7) on the Circular Economy. - Your program design must be comprehensive, feasible, and include active engagement of large enterprises as 'Technology Recipients' and 'Ecosystem Partners'. Grant Program Context: This call is part of a larger funding initiative, the 'European Funds for a Modern Economy 2021-2027 (FENG)' program. It appears to be a specific call within a recurring program, as indicated by its numbering and the overall program context.	Funding Up to 10000000.00 PLN Deadline Sept. 17, 2025, 2 p.m.	Details
Platforma Startowa Unicorn Hub – edycja II Unicorn Hub 2.0 (FEPW 01.01) Programme: Fundusze Europejskie dla Polski Wschodniej (FEPW) 1.1	The 'Platforma Startowa Unicorn Hub – edycja II' grant aims to help individuals and teams with innovative ideas develop them into profitable products or services. This program provides comprehensive incubation support and a small financial grant, acting as a preparatory step for larger follow-on funding opportunities within Eastern Poland. This grant is SECTOR-AGNOSTIC, focusing on product innovation rather than specific industries. It targets individuals or teams who are ready to establish a capital company in Eastern Poland after the incubation period. The core objective is to foster the creation of new, innovative businesses in the specified geographic area. Key filtering criteria include the novelty and exclusivity of the innovative idea, and the applicant's commitment to establishing a business within Eastern Poland.	Funding Up to 32000.00 PLN Deadline May 10, 2027, 9:59 p.m.	Details
Platformy Startowe Start in… FEPW 01.01 Programme: Platformy startowe dla nowych pomysłów	This grant aims to help individuals and teams develop a novel, innovative business idea into a viable product (MVP) and a sustainable business model through a comprehensive incubation program. The 'Start in…' platform specifically focuses on innovative ideas within the automotive industry. It targets individuals or teams of individuals who possess a unique product innovation idea at a national level and are prepared to establish a capital company in Eastern Poland. The program provides the necessary framework and support to bring these ideas to market readiness. This is a SECTOR-SPECIFIC grant, with the 'Start in…' platform specifically targeting the automotive industry. Geographically, applicants must be willing to establish their business in one of the designated regions of Eastern Poland (Lubelskie, Podkarpackie, Podlaskie, Świętokrzyskie, Warmińsko-Mazurskie, or Mazowieckie, excluding the Warsaw metropolitan area). The program runs in successive rounds until March 2027, making it a recurring opportunity for innovators.	Funding Up to 90000.00 PLN Deadline March 7, 2027, 10:59 p.m.	Details
Platforma Startowa - Centralny Akcelerator Innowacji – Mazovian StartUPolis Platforma Startowa - Centralny Akcelerator Innowacji – Mazovian StartUPolis Programme: Platformy startowe dla nowych pomysłów	This grant, 'Mazovian StartUPolis', aims to transform innovative business ideas from individuals or teams into profitable products or services through a structured incubation program. The primary target recipients are individuals or teams with a new business idea, intending to form a capital company (spółka kapitałowa) in Eastern Poland. They are considered pre-revenue startups at the idea stage. This grant is SECTOR-SPECIFIC, prioritizing certain high-tech industries. Its geographic scope is limited to Eastern Poland (Polska Wschodnia); applicants must be ready to establish their business within this region. Key filtering criteria for initial screening include: the idea must be a product innovation at a national level, currently not an active business, and applicants must have exclusive rights to the idea. A willingness to establish a capital company in Eastern Poland is crucial. This is part of the broader 'Platformy startowe dla nowych pomysłów' (Startup platforms for new ideas) program, with applications accepted in rolling rounds until June 2, 2026.	Funding Up to 600000.00 PLN Deadline June 2, 2026, 9:59 p.m.	Details
Platforma startowa HugeTECH Revolution HugeTECH Revolution Programme: Fundusze Europejskie dla Polski Wschodniej 2021-2027 (FEPW), Działanie 1.1: Platformy startowe dla nowych pomysłów	The Platforma startowa HugeTECH Revolution grant aims to support individuals and teams in transforming their innovative business ideas into profitable, market-ready products, specifically Minimum Viable Products (MVPs). This is achieved through a comprehensive incubation program that includes expert mentorship, various support services, and direct financial assistance. This grant targets individuals and teams of individuals who are ready to establish a new capital company (effectively, a startup) in Eastern Poland. The program is SECTOR-AGNOSTIC, meaning it welcomes innovative product ideas from any area, but it also has a specific focus track for projects related to health, aiming to improve health and quality of life. Key criteria for initial screening include the novelty and national-level innovation of the product idea, the applicant's exclusive rights to it, the readiness to register a company in Eastern Poland, and the fact that the idea must not have been previously commercialized or subject to business activity. The program is part of a recurring national initiative, 'Platformy startowe' (Startup Platforms), offered in rounds.	Funding Up to 43000.00 PLN Deadline Jan. 31, 2026, 10:59 p.m.	Details
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) RFA-FD-25-001 Programme: FDA Rare Neurodegenerative Disease Grant Program	The core objective of this grant, RFA-FD-25-001, is to fund clinical trials that evaluate the efficacy and/or safety of medical products to address unmet needs in rare neurodegenerative diseases for both children and adults. The goal is to facilitate drug development, increase the number of approved treatments, and have a broad positive impact on rare disease drug development. This is a SECTOR-SPECIFIC grant, exclusively targeting the Healthcare sector, particularly focusing on research and development for rare neurodegenerative conditions. The target recipients are organizations capable of conducting clinical trials. This includes a wide range of entity types such as higher education institutions, non-profits, for-profit organizations, and various government entities. Geographically, applicants from the United States are eligible, and importantly, non-domestic (non-U.S.) entities (Foreign Organizations) are also explicitly eligible to apply. This implies a global reach for eligible applicants, though the primary context is U.S. regulatory alignment. Key filtering criteria for initial screening include a clear proposal for a clinical trial (not just research), a focus on rare neurodegenerative diseases as defined by FDA, and a commitment to supporting a new product indication or change in labeling. This grant opportunity is recurring, with application cycles expected annually, building upon the FDA's Rare Neurodegenerative Disease Grant Program established under the 'Accelerating Access to Critical Therapies for ALS Act'.	Funding Up to 900000.00 USD Deadline Oct. 22, 2025, 3:59 a.m.	Details
Integration of human driving behaviour in the validation of CCAM systems (CCAM Partnership) 48346900TOPICSen Programme: Horizon Europe	This grant, titled 'Integration of human driving behaviour in the validation of CCAM systems (CCAM Partnership)', aims to develop and validate human behavioural models for Connected, Cooperative, and Automated Mobility (CCAM) systems. The core objective is to integrate these models into virtual safety validation processes for mixed traffic simulations, leading to the design of safer, more human-like CCAM system behavior that is easily anticipatable by all road users. This is a SECTOR-SPECIFIC grant primarily targeting the transport, automotive, and technology sectors, with a strong focus on advanced mobility, automation, and artificial intelligence. The grant is designed for research-performing organizations, including universities, research institutes, and enterprises (both SMEs and larger companies) with expertise in human behavior modeling, CCAM systems, and virtual validation. Geographically, organizations from EU Member States and countries associated with Horizon Europe are eligible for funding. International cooperation is explicitly encouraged with research stakeholders in Japan, the United States, and other relevant third countries, particularly for data capture and validation, though direct funding eligibility for these third countries should be confirmed via Annex B of the Work Programme General Annexes. Key filtering criteria for initial screening include a strong background in Research and Innovation Actions (RIA), a focus on advancing technology readiness to TRL 5, and the capacity to engage in international collaboration on complex R&D projects related to automated driving. This grant is part of the recurring Horizon Europe Framework Programme (2021-2027), specifically under Cluster 5, and represents a specific call within that broader program.	Funding Up to 5000000.00 EUR Deadline Jan. 20, 2026, midnight	Details
Towards modern, integrated, and effective fisheries monitoring, control and surveillance (MCS) systems 48214180TOPICSen Programme: Horizon Europe	This grant, part of the 'Food, Bioeconomy, Natural Resources, Agriculture and Environment' program, aims to modernize and enhance systems for monitoring, controlling, and surveilling fisheries. It seeks innovative solutions to improve data collection, efficiency, and enforcement, particularly targeting illegal, unreported, and unregulated (IUU) fishing practices. The grant is SECTOR-SPECIFIC, focusing on organizations involved in fisheries, aquaculture, marine environment, and related technological development. It targets a broad range of entities including public and private sector actors, researchers, SMEs, local authorities, communities, NGOs, and civil society. Geographically, projects must include case studies covering EU small-scale fisheries in European Seas (Mediterranean, Baltic, Black, North East Atlantic), EU small-scale fisheries in EU Outermost Regions, recreational fisheries in EU waters, and EU long-distance fisheries in the Indian Ocean or Pacific Ocean. The primary goal is to contribute to sustainable, resilient, and inclusive food systems while protecting marine ecosystems.	Funding Up to 6000000.00 EUR Deadline Sept. 16, 2025, midnight	Details
Investitionszuschuss: Berliner InvestitionsBONUS - Funding for Future-Oriented and Sustainable Investments in Berlin Berliner InvestitionsBONUS Programme: Wirtschaftsförderprogramm Berliner InvestitionsBONUS	This grant, the Berliner InvestitionsBONUS, aims to provide financial incentives to Berlin-based businesses, including small, medium, and large enterprises, as well as sole proprietors and freelancers. Its core objective is to support necessary future-oriented investments that enhance competitiveness, create or preserve jobs, and contribute to the economic future of Berlin. The grant places a significant emphasis on promoting sustainable investment measures.	Funding Up to 7500000.00 EUR Deadline Dec. 31, 2025, midnight	Details
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) PAR-25-357 Programme: National Institutes of Health (NIH)	The core objective of this grant is to support secondary data analysis of existing human vision-related clinical, epidemiologic, and healthcare data. The goal is to investigate new scientific ideas, models, systems, tools, or methods that have the potential for significant impact in areas relevant to the National Eye Institute's (NEI) mission. The grant explicitly supports research that can deepen the understanding of vision health problems, address leading causes of blindness, and enhance the quality of life for individuals with impaired vision. This is a SECTOR-SPECIFIC grant, focused exclusively on vision research. It targets a broad range of organizations, including higher education institutions, nonprofits, for-profit organizations (including small businesses), and various government entities, both domestic and foreign, with no explicit size limitations beyond their categorization. The geographic scope is global, as foreign organizations are eligible to apply. Key filtering criteria for initial screening include: projects must propose secondary data analysis of human vision-related data only, cannot involve the collection of new data, cannot analyze animal data, and cannot be used to support ongoing data analysis or data set maintenance. The existing data must already be in an analyzable format. This funding opportunity is a reissue of PAR-22-141, indicating it is a recurring program, specifically an R21 Exploratory/Developmental Research Grant under the NIH/NEI.	Funding Up to 275000.00 USD Deadline Nov. 16, 2027, 5 p.m.	Details
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) PAR-25-090 Programme: National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	This grant, PAR-25-090, is a planning cooperative agreement (U34) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) designed to support the initial administrative and preparatory phases of investigator-initiated, high-risk multi-center clinical studies. The primary objective is to facilitate the rigorous planning and documentation required before participant recruitment can begin for complex clinical studies, ultimately leading to a full-scale clinical study (U01). This grant is SECTOR-SPECIFIC, focusing exclusively on diseases within the mission of NIDDK (e.g., diabetes, digestive, and kidney diseases). It targets research institutions, non-profits, and for-profit organizations (including small businesses) based in the United States. Foreign organizations are not eligible to apply, but foreign components (e.g., for specific data analyses) of US-based organizations are allowed. Key filtering criteria: The proposed clinical study must be high-risk, as defined by NIDDK, and multi-center (more than one clinical research center). It's a planning grant, not for conducting preliminary data collection, pilot studies, or the clinical study itself. Consultation with NIDDK staff is strongly encouraged prior to application. This is a recurring grant opportunity, reissued from PAR-24-094, indicating an ongoing program context for supporting high-risk clinical study planning.	Funding Up to 225000.00 USD Deadline June 10, 2027, 9 p.m.	Details
Assessment of Technology Infrastructure needs in Ukraine (CSA) HORIZON-CL4-INDUSTRY-2025-01-HUMAN-66 Programme: Horizon Europe	The core objective of this grant is to comprehensively assess the Technology Infrastructure needs in Ukraine. This includes understanding the current landscape, evaluating war-related damage, identifying specific user needs (both public and private sector), and developing a strategic investment agenda for the post-war reconstruction and future technological development of Ukrainian industry. The grant also aims to identify and pilot integrated networks of Technology Centres within Ukraine to strengthen the connection between research and industry. This grant targets organizations involved in research and innovation ecosystems, such as Research and Technology Organisations (RTOs), technical universities, research institutes, technology centres, and private sector entities capable of engaging in a collaborative, consortium-based approach. The grant is SECTOR-SPECIFIC, focusing on 'Technology Infrastructure' and the broader 'industrial' and 'digital' sectors, particularly in the context of Ukraine's recovery and advancement. The geographic scope for the project's activities is primarily Ukraine. Eligible applicants for funding are entities from EU Member States and countries associated with the Horizon Europe programme, which includes Ukraine. This grant is part of the Horizon Europe 2025 Work Programme and is offered as a single-stage call. Key filtering criteria for this opportunity include a strong focus on Ukraine's technological landscape, post-war reconstruction, and the development of robust technology infrastructure networks. Applicants should have expertise in R&I ecosystems and be prepared to act as a Coordination and Support Action (CSA).	Funding Up to 1500000.00 EUR Deadline Sept. 23, 2025, midnight	Details
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) RFA-MD-24-006 Programme: Small Business Innovation Research (SBIR) Grant	The core objective of this grant is to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. The aim is to develop innovative products, processes, or services for commercialization that will improve minority health and/or reduce and ultimately eliminate health disparities in one or more populations that experience health disparities within the United States and its territories. The grant is SECTOR-SPECIFIC, primarily targeting healthcare and health technology innovations. It seeks solutions that are effective, affordable, and culturally acceptable for racial/ethnic minority populations, disadvantaged socioeconomic groups, and underserved rural populations in the U.S. This is a recurring grant program, reissued annually, with multiple application cycles.	Funding Up to 2045816.00 USD Deadline Dec. 9, 2026, 5 p.m.	Details
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-25-370 Programme: National Institutes of Health	Grant Purpose and Target This grant, the 'Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)', aims to fund small-scale research projects that investigate the ethical, legal, and social implications arising from human genetics and genomics. It is designed for individual investigators or small teams. Core Objective To study the ethical, legal, and social implications (ELSI) of human genetics and genomics, including normative, conceptual, legal, economic, philosophical, anthropological, or historical analyses, as well as preliminary data collection or secondary analysis of existing data. Target Recipients This grant targets various organizational types, including: Higher Education Institutions, Nonprofits (both 501(c)(3) and others), For-Profit Organizations (including small businesses), Local Governments, Indian/Native American Tribal Governments, Federal Agencies, and other entities such as independent school districts, public housing authorities, faith-based/community-based organizations, and foreign organizations. It is suitable for projects led by single investigators or small teams. Sector Focus This grant is SECTOR-SPECIFIC, primarily focused on the fields of Genetics, Genomics, Health, and Social Sciences. It encourages applications from a wide range of academic disciplines, including bioethics, humanities, behavioral sciences, law, and data science. Geographic Scope This opportunity has a broad international geographic scope, as Non-domestic (non-U.S.) Entities (Foreign Organizations) are explicitly eligible to apply. Key Filtering Criteria Your project must focus on the ethical, legal, or social implications of human genetics and genomics. It should be a small, self-contained research project. The budget limit is $50,000 in direct costs per year. It can involve preliminary data collection or secondary analysis of existing data. Grant Context and Frequency This funding opportunity (PAR-25-370) is a reissue of a previous program (PAR-23-295), indicating it is a recurring grant program. It is part of a larger series of ELSI funding opportunities offered by the NIH, which also includes R21 (Exploratory/Developmental) and R01 (Research Project) mechanisms for different project scopes and durations.	Funding Up to 50000.00 USD Deadline Nov. 16, 2026, 10 p.m.	Details
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) PAR-23-158 Programme: National Institutes of Health (NIH)	This grant, known as the 'Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required),' aims to fund exploratory and developmental clinical research that investigates the neurobiological mechanisms underlying Substance Use Disorders (SUDs). This includes fundamental brain circuitry and behavior related to substance use. It specifically targets basic science experimental studies involving human participants that fit the NIH definition of both a clinical trial and basic research. This funding opportunity is SECTOR-SPECIFIC, focusing on neuroscience, particularly within the context of addiction and substance use disorders. It is open to a broad range of organizational types, including research institutions, non-profits, and even for-profit entities, in the U.S. and internationally. It is a recurring grant opportunity with multiple application cycles through March 2026.	Funding Up to 500000.00 USD Deadline March 13, 2026, 5 p.m.	Details
Federated CCAM data exchange platform (CCAM Partnership) HORIZON-CL5-2026-01-D6-06 Programme: Horizon Europe	The core objective of this grant is to establish a federated, sustainable data exchange platform for Connected, Cooperative and Automated Mobility (CCAM). This platform will facilitate data sharing for research and innovation, large-scale demonstrations, and deployment within the CCAM industry. This is a SECTOR-SPECIFIC grant, focusing exclusively on Connected, Cooperative and Automated Mobility. Target recipients include a broad range of public and private organizations such as companies (Original Equipment Manufacturers, Tier X suppliers), research institutes, traffic managers, infrastructure providers, national authorities, and social partners. Geographically, the grant focuses on European entities (EU Member States and Associated Countries), while also encouraging international cooperation with Japan, the US, and other third countries. Key filtering criteria for potential applicants include a strong focus on CCAM data exchange, experience in platform development, and a willingness to align with existing EU data space initiatives. This specific grant call is part of Horizon Europe's multi-annual work programme for 2026.	Funding Up to 4000000.00 EUR Deadline Jan. 20, 2026, midnight	Details
Reliable data and practices to measure and calculate transport emissions in multimodal transport chains HORIZON-CL5-2026-01-D6-09 Programme: Horizon Europe	The core objective of this grant is to improve the accuracy and reliability of data and practices used to measure and calculate transport emissions, particularly in multimodal transport chains. It aims to support the implementation of existing and forthcoming European Union (EU) regulatory initiatives, such as FuelEU Maritime, ReFuelEU Aviation, and the proposed CountEmissions EU. This grant is SECTOR-SPECIFIC, focusing primarily on the TRANSPORTATION and ENVIRONMENT sectors. It targets organizations capable of conducting research, developing methodologies, and facilitating coordination and support actions. The expected recipients are typically consortia comprising research institutions, businesses, and public bodies. Geographically, the grant is open to entities from EU Member States and countries associated with the Horizon Europe programme. The work undertaken will have a direct impact on EU policy and regulations, making a strong connection to the European context essential. Key filtering criteria for potential applicants include demonstrated expertise in transport emissions, data science, environmental policy, multimodal transport, and the application of new technologies like Artificial Intelligence (AI) in data analysis. Applicants should be prepared to collaborate within a consortium and engage with diverse stakeholders to develop scientifically sound frameworks and practical solutions. This specific topic is part of the Horizon Europe Work Programme 2025, suggesting it is a targeted, one-time call within the broader programme.	Funding Up to 3500000.00 EUR Deadline Jan. 20, 2026, midnight	Details

Startup Hub: Poland Booster Accelerator Program

Startup Hub: Poland Booster

Programme: Program Akceleracyjny

The 'Startup Hub: Poland Booster' program aims to support startups and small to medium-sized enterprises (SMEs) through various acceleration paths. Its core objective is to foster business growth, facilitate market entry (both domestic and international), and prepare entities for investment. The program provides equity-free grants as de minimis aid. This grant is SECTOR-AGNOSTIC, with one specific acceleration path dedicated to it. However, the other paths (B2B, VC, Poland Prize, Go-Global) are also not limited to specific industries, focusing on business models, investment readiness, or international expansion regardless of sector. The target recipients are 'startups' (defined as micro or small enterprises operating for no longer than 5 years) and 'micro, small, and medium enterprises' (MSP). The geographic scope covers Poland and extends abroad, with explicit mentions of the Czech Republic and Hungary for international market entry. Key filtering criteria for this grant include the organization's legal classification (startup or MSP), its operational age (for startups), and its strategic interest in acceleration, B2B collaboration, investment, or internationalization. This is a recurring grant program with multiple application rounds.

Funding

Up to 400000.00 PLN

Deadline

Jan. 31, 2026, 10:59 p.m.

Details

Strefa Akceleracji – Acceleration Program for Innovative Startups

Strefa Akceleracji

Programme: Strefa Akceleracji Program

The 'Strefa Akceleracji' (Acceleration Zone) grant aims to support innovative micro and small startups in Poland by providing specialized knowledge, experience, tools, and financial grants. Its core objective is to accelerate the development and implementation of innovative business ideas, particularly through technology test deployments or expansion into global markets. This grant is primarily for startups, specifically defined as micro and small enterprises. It is SECTOR-SPECIFIC, focusing on areas such as the Marine Industry, Industry 4.0, and Life Science. While the program is based in Poland and managed by Polish entities, the applicant's company location (headquarters) is not a strict barrier for eligibility. The 'Go Global' track explicitly encourages international market expansion, targeting beneficiaries worldwide, though the funding mechanism is managed locally. Key filtering criteria for initial screening include being an innovative micro or small enterprise, generally registered for less than 5 years, and operating within the specified focus sectors. Projects must demonstrate a specific Technology Readiness Level (TRL) or market traction depending on the chosen acceleration path. The grant is recurring, with multiple application rounds planned.

Funding

Up to 400000.00 PLN

Deadline

Jan. 31, 2026, 11:59 p.m.

Details

Startup Spark 3.0 Acceleration Program for Tech Startups

Startup Spark 3.0

Programme: Łódzka Specjalna Strefa Ekonomiczna S.A. Acceleration Programs

The 'Startup Spark 3.0' program aims to support micro and small enterprises, specifically startups, in developing new technologies for various business and industrial applications. It also seeks to facilitate their expansion into international markets through a structured acceleration and post-acceleration program. This grant is primarily SECTOR-SPECIFIC in its core technology focus areas (robotics, blockchain, etc.), but it also offers a 'sector-agnostic' track for how those technologies are applied. Target recipients are startups classified as micro and small enterprises. Geographically, applicants must be from Poland. The 'Go Global' track specifically targets expansion into markets such as Israel, the USA, and Spain. Key filtering criteria for initial screening include being a Polish startup, meeting the micro or small enterprise definition, and developing solutions in automatics, robotics, web3, blockchain, sustainable development, or ESG. This is a recurring grant program, being the 'next iteration' of an accelerator initiative run by the Łódź Special Economic Zone since 2017.

Funding

Up to 400000.00 PLN

Deadline

Jan. 31, 2026, 10:59 p.m.

Details

Startup Booster Poland – Scale Up Green – Call for Accelerators

FENG.02.28-IP.02-001/25

Programme: Fundusze Europejskie dla Nowoczesnej Gospodarki

This grant, 'Startup Booster Poland – Scale Up Green', aims to select and fund organizations (accelerators) that will run professional acceleration programs. The core objective is to support innovative startups developing solutions for the Circular Economy (known as GOZ in Polish, which stands for Gospodarka o Obiegu Zamkniętym). These programs must facilitate the piloting and potential implementation of startup solutions within large enterprises (called 'Technology Recipients') to help these large businesses transition towards a circular economy model. A crucial part of the projects is also to spread knowledge about the Circular Economy among large enterprises in Poland. This is a SECTOR-SPECIFIC grant, focused entirely on the Circular Economy and related green technologies. Target Recipients: The funding is for entities operating in support of innovation and economic development. These include, but are not limited to, technology transfer centers, innovation centers, technological incubators, academic entrepreneurship incubators, and technology parks. The grant directly benefits these accelerators, who in turn support startups and large enterprises. Geographic Scope: Projects must be implemented in Poland. Key Filtering Criteria for Initial Screening: - Your organization must be an established entity supporting innovation and registered in Poland. - You must have proven experience in running acceleration programs, specifically those involving Circular Economy (GOZ) solutions and collaboration with potential technology recipients. - Your proposed acceleration program must align with Poland's National Smart Specialization (KIS 7) on the Circular Economy. - Your program design must be comprehensive, feasible, and include active engagement of large enterprises as 'Technology Recipients' and 'Ecosystem Partners'. Grant Program Context: This call is part of a larger funding initiative, the 'European Funds for a Modern Economy 2021-2027 (FENG)' program. It appears to be a specific call within a recurring program, as indicated by its numbering and the overall program context.

Funding

Up to 10000000.00 PLN

Deadline

Sept. 17, 2025, 2 p.m.

Details

Platforma Startowa Unicorn Hub – edycja II

Unicorn Hub 2.0 (FEPW 01.01)

Programme: Fundusze Europejskie dla Polski Wschodniej (FEPW) 1.1

The 'Platforma Startowa Unicorn Hub – edycja II' grant aims to help individuals and teams with innovative ideas develop them into profitable products or services. This program provides comprehensive incubation support and a small financial grant, acting as a preparatory step for larger follow-on funding opportunities within Eastern Poland. This grant is SECTOR-AGNOSTIC, focusing on product innovation rather than specific industries. It targets individuals or teams who are ready to establish a capital company in Eastern Poland after the incubation period. The core objective is to foster the creation of new, innovative businesses in the specified geographic area. Key filtering criteria include the novelty and exclusivity of the innovative idea, and the applicant's commitment to establishing a business within Eastern Poland.

Funding

Up to 32000.00 PLN

Deadline

May 10, 2027, 9:59 p.m.

Details

Platformy Startowe Start in…

FEPW 01.01

Programme: Platformy startowe dla nowych pomysłów

This grant aims to help individuals and teams develop a novel, innovative business idea into a viable product (MVP) and a sustainable business model through a comprehensive incubation program. The 'Start in…' platform specifically focuses on innovative ideas within the automotive industry. It targets individuals or teams of individuals who possess a unique product innovation idea at a national level and are prepared to establish a capital company in Eastern Poland. The program provides the necessary framework and support to bring these ideas to market readiness. This is a SECTOR-SPECIFIC grant, with the 'Start in…' platform specifically targeting the automotive industry. Geographically, applicants must be willing to establish their business in one of the designated regions of Eastern Poland (Lubelskie, Podkarpackie, Podlaskie, Świętokrzyskie, Warmińsko-Mazurskie, or Mazowieckie, excluding the Warsaw metropolitan area). The program runs in successive rounds until March 2027, making it a recurring opportunity for innovators.

Funding

Up to 90000.00 PLN

Deadline

March 7, 2027, 10:59 p.m.

Details

Platforma Startowa - Centralny Akcelerator Innowacji – Mazovian StartUPolis

Programme: Platformy startowe dla nowych pomysłów

This grant, 'Mazovian StartUPolis', aims to transform innovative business ideas from individuals or teams into profitable products or services through a structured incubation program. The primary target recipients are individuals or teams with a new business idea, intending to form a capital company (spółka kapitałowa) in Eastern Poland. They are considered pre-revenue startups at the idea stage. This grant is SECTOR-SPECIFIC, prioritizing certain high-tech industries. Its geographic scope is limited to Eastern Poland (Polska Wschodnia); applicants must be ready to establish their business within this region. Key filtering criteria for initial screening include: the idea must be a product innovation at a national level, currently not an active business, and applicants must have exclusive rights to the idea. A willingness to establish a capital company in Eastern Poland is crucial. This is part of the broader 'Platformy startowe dla nowych pomysłów' (Startup platforms for new ideas) program, with applications accepted in rolling rounds until June 2, 2026.

Funding

Up to 600000.00 PLN

Deadline

June 2, 2026, 9:59 p.m.

Details

Platforma startowa HugeTECH Revolution

HugeTECH Revolution

Programme: Fundusze Europejskie dla Polski Wschodniej 2021-2027 (FEPW), Działanie 1.1: Platformy startowe dla nowych pomysłów

The Platforma startowa HugeTECH Revolution grant aims to support individuals and teams in transforming their innovative business ideas into profitable, market-ready products, specifically Minimum Viable Products (MVPs). This is achieved through a comprehensive incubation program that includes expert mentorship, various support services, and direct financial assistance. This grant targets individuals and teams of individuals who are ready to establish a new capital company (effectively, a startup) in Eastern Poland. The program is SECTOR-AGNOSTIC, meaning it welcomes innovative product ideas from any area, but it also has a specific focus track for projects related to health, aiming to improve health and quality of life. Key criteria for initial screening include the novelty and national-level innovation of the product idea, the applicant's exclusive rights to it, the readiness to register a company in Eastern Poland, and the fact that the idea must not have been previously commercialized or subject to business activity. The program is part of a recurring national initiative, 'Platformy startowe' (Startup Platforms), offered in rounds.

Funding

Up to 43000.00 PLN

Deadline

Jan. 31, 2026, 10:59 p.m.

Details

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01)

RFA-FD-25-001

Programme: FDA Rare Neurodegenerative Disease Grant Program

The core objective of this grant, RFA-FD-25-001, is to fund clinical trials that evaluate the efficacy and/or safety of medical products to address unmet needs in rare neurodegenerative diseases for both children and adults. The goal is to facilitate drug development, increase the number of approved treatments, and have a broad positive impact on rare disease drug development. This is a SECTOR-SPECIFIC grant, exclusively targeting the Healthcare sector, particularly focusing on research and development for rare neurodegenerative conditions. The target recipients are organizations capable of conducting clinical trials. This includes a wide range of entity types such as higher education institutions, non-profits, for-profit organizations, and various government entities. Geographically, applicants from the United States are eligible, and importantly, non-domestic (non-U.S.) entities (Foreign Organizations) are also explicitly eligible to apply. This implies a global reach for eligible applicants, though the primary context is U.S. regulatory alignment. Key filtering criteria for initial screening include a clear proposal for a clinical trial (not just research), a focus on rare neurodegenerative diseases as defined by FDA, and a commitment to supporting a new product indication or change in labeling. This grant opportunity is recurring, with application cycles expected annually, building upon the FDA's Rare Neurodegenerative Disease Grant Program established under the 'Accelerating Access to Critical Therapies for ALS Act'.

Funding

Up to 900000.00 USD

Deadline

Oct. 22, 2025, 3:59 a.m.

Details

Integration of human driving behaviour in the validation of CCAM systems (CCAM Partnership)

48346900TOPICSen

Programme: Horizon Europe

This grant, titled 'Integration of human driving behaviour in the validation of CCAM systems (CCAM Partnership)', aims to develop and validate human behavioural models for Connected, Cooperative, and Automated Mobility (CCAM) systems. The core objective is to integrate these models into virtual safety validation processes for mixed traffic simulations, leading to the design of safer, more human-like CCAM system behavior that is easily anticipatable by all road users. This is a SECTOR-SPECIFIC grant primarily targeting the transport, automotive, and technology sectors, with a strong focus on advanced mobility, automation, and artificial intelligence. The grant is designed for research-performing organizations, including universities, research institutes, and enterprises (both SMEs and larger companies) with expertise in human behavior modeling, CCAM systems, and virtual validation. Geographically, organizations from EU Member States and countries associated with Horizon Europe are eligible for funding. International cooperation is explicitly encouraged with research stakeholders in Japan, the United States, and other relevant third countries, particularly for data capture and validation, though direct funding eligibility for these third countries should be confirmed via Annex B of the Work Programme General Annexes. Key filtering criteria for initial screening include a strong background in Research and Innovation Actions (RIA), a focus on advancing technology readiness to TRL 5, and the capacity to engage in international collaboration on complex R&D projects related to automated driving. This grant is part of the recurring Horizon Europe Framework Programme (2021-2027), specifically under Cluster 5, and represents a specific call within that broader program.

Funding

Up to 5000000.00 EUR

Deadline

Jan. 20, 2026, midnight

Details

Towards modern, integrated, and effective fisheries monitoring, control and surveillance (MCS) systems

48214180TOPICSen

Programme: Horizon Europe

This grant, part of the 'Food, Bioeconomy, Natural Resources, Agriculture and Environment' program, aims to modernize and enhance systems for monitoring, controlling, and surveilling fisheries. It seeks innovative solutions to improve data collection, efficiency, and enforcement, particularly targeting illegal, unreported, and unregulated (IUU) fishing practices. The grant is SECTOR-SPECIFIC, focusing on organizations involved in fisheries, aquaculture, marine environment, and related technological development. It targets a broad range of entities including public and private sector actors, researchers, SMEs, local authorities, communities, NGOs, and civil society. Geographically, projects must include case studies covering EU small-scale fisheries in European Seas (Mediterranean, Baltic, Black, North East Atlantic), EU small-scale fisheries in EU Outermost Regions, recreational fisheries in EU waters, and EU long-distance fisheries in the Indian Ocean or Pacific Ocean. The primary goal is to contribute to sustainable, resilient, and inclusive food systems while protecting marine ecosystems.

Funding

Up to 6000000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

Investitionszuschuss: Berliner InvestitionsBONUS - Funding for Future-Oriented and Sustainable Investments in Berlin

Berliner InvestitionsBONUS

Programme: Wirtschaftsförderprogramm Berliner InvestitionsBONUS

This grant, the Berliner InvestitionsBONUS, aims to provide financial incentives to Berlin-based businesses, including small, medium, and large enterprises, as well as sole proprietors and freelancers. Its core objective is to support necessary future-oriented investments that enhance competitiveness, create or preserve jobs, and contribute to the economic future of Berlin. The grant places a significant emphasis on promoting sustainable investment measures.

Funding

Up to 7500000.00 EUR

Deadline

Dec. 31, 2025, midnight

Details

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

PAR-25-357

Programme: National Institutes of Health (NIH)

The core objective of this grant is to support secondary data analysis of existing human vision-related clinical, epidemiologic, and healthcare data. The goal is to investigate new scientific ideas, models, systems, tools, or methods that have the potential for significant impact in areas relevant to the National Eye Institute's (NEI) mission. The grant explicitly supports research that can deepen the understanding of vision health problems, address leading causes of blindness, and enhance the quality of life for individuals with impaired vision. This is a SECTOR-SPECIFIC grant, focused exclusively on vision research. It targets a broad range of organizations, including higher education institutions, nonprofits, for-profit organizations (including small businesses), and various government entities, both domestic and foreign, with no explicit size limitations beyond their categorization. The geographic scope is global, as foreign organizations are eligible to apply. Key filtering criteria for initial screening include: projects must propose secondary data analysis of human vision-related data only, cannot involve the collection of new data, cannot analyze animal data, and cannot be used to support ongoing data analysis or data set maintenance. The existing data must already be in an analyzable format. This funding opportunity is a reissue of PAR-22-141, indicating it is a recurring program, specifically an R21 Exploratory/Developmental Research Grant under the NIH/NEI.

Funding

Up to 275000.00 USD

Deadline

Nov. 16, 2027, 5 p.m.

Details

NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)

PAR-25-090

Programme: National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

This grant, PAR-25-090, is a planning cooperative agreement (U34) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) designed to support the initial administrative and preparatory phases of investigator-initiated, high-risk multi-center clinical studies. The primary objective is to facilitate the rigorous planning and documentation required before participant recruitment can begin for complex clinical studies, ultimately leading to a full-scale clinical study (U01). This grant is SECTOR-SPECIFIC, focusing exclusively on diseases within the mission of NIDDK (e.g., diabetes, digestive, and kidney diseases). It targets research institutions, non-profits, and for-profit organizations (including small businesses) based in the United States. Foreign organizations are not eligible to apply, but foreign components (e.g., for specific data analyses) of US-based organizations are allowed. Key filtering criteria: The proposed clinical study must be high-risk, as defined by NIDDK, and multi-center (more than one clinical research center). It's a planning grant, not for conducting preliminary data collection, pilot studies, or the clinical study itself. Consultation with NIDDK staff is strongly encouraged prior to application. This is a recurring grant opportunity, reissued from PAR-24-094, indicating an ongoing program context for supporting high-risk clinical study planning.

Funding

Up to 225000.00 USD

Deadline

June 10, 2027, 9 p.m.

Details

Assessment of Technology Infrastructure needs in Ukraine (CSA)

HORIZON-CL4-INDUSTRY-2025-01-HUMAN-66

Programme: Horizon Europe

The core objective of this grant is to comprehensively assess the Technology Infrastructure needs in Ukraine. This includes understanding the current landscape, evaluating war-related damage, identifying specific user needs (both public and private sector), and developing a strategic investment agenda for the post-war reconstruction and future technological development of Ukrainian industry. The grant also aims to identify and pilot integrated networks of Technology Centres within Ukraine to strengthen the connection between research and industry. This grant targets organizations involved in research and innovation ecosystems, such as Research and Technology Organisations (RTOs), technical universities, research institutes, technology centres, and private sector entities capable of engaging in a collaborative, consortium-based approach. The grant is SECTOR-SPECIFIC, focusing on 'Technology Infrastructure' and the broader 'industrial' and 'digital' sectors, particularly in the context of Ukraine's recovery and advancement. The geographic scope for the project's activities is primarily Ukraine. Eligible applicants for funding are entities from EU Member States and countries associated with the Horizon Europe programme, which includes Ukraine. This grant is part of the Horizon Europe 2025 Work Programme and is offered as a single-stage call. Key filtering criteria for this opportunity include a strong focus on Ukraine's technological landscape, post-war reconstruction, and the development of robust technology infrastructure networks. Applicants should have expertise in R&I ecosystems and be prepared to act as a Coordination and Support Action (CSA).

Funding

Up to 1500000.00 EUR

Deadline

Sept. 23, 2025, midnight

Details

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

RFA-MD-24-006

Programme: Small Business Innovation Research (SBIR) Grant

The core objective of this grant is to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. The aim is to develop innovative products, processes, or services for commercialization that will improve minority health and/or reduce and ultimately eliminate health disparities in one or more populations that experience health disparities within the United States and its territories. The grant is SECTOR-SPECIFIC, primarily targeting healthcare and health technology innovations. It seeks solutions that are effective, affordable, and culturally acceptable for racial/ethnic minority populations, disadvantaged socioeconomic groups, and underserved rural populations in the U.S. This is a recurring grant program, reissued annually, with multiple application cycles.

Funding

Up to 2045816.00 USD

Deadline

Dec. 9, 2026, 5 p.m.

Details

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

PAR-25-370

Programme: National Institutes of Health

Grant Purpose and Target This grant, the 'Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)', aims to fund small-scale research projects that investigate the ethical, legal, and social implications arising from human genetics and genomics. It is designed for individual investigators or small teams. Core Objective To study the ethical, legal, and social implications (ELSI) of human genetics and genomics, including normative, conceptual, legal, economic, philosophical, anthropological, or historical analyses, as well as preliminary data collection or secondary analysis of existing data. Target Recipients This grant targets various organizational types, including: Higher Education Institutions, Nonprofits (both 501(c)(3) and others), For-Profit Organizations (including small businesses), Local Governments, Indian/Native American Tribal Governments, Federal Agencies, and other entities such as independent school districts, public housing authorities, faith-based/community-based organizations, and foreign organizations. It is suitable for projects led by single investigators or small teams. Sector Focus This grant is SECTOR-SPECIFIC, primarily focused on the fields of Genetics, Genomics, Health, and Social Sciences. It encourages applications from a wide range of academic disciplines, including bioethics, humanities, behavioral sciences, law, and data science. Geographic Scope This opportunity has a broad international geographic scope, as Non-domestic (non-U.S.) Entities (Foreign Organizations) are explicitly eligible to apply. Key Filtering Criteria

Your project must focus on the ethical, legal, or social implications of human genetics and genomics.
It should be a small, self-contained research project.
The budget limit is $50,000 in direct costs per year.
It can involve preliminary data collection or secondary analysis of existing data.

Grant Context and Frequency This funding opportunity (PAR-25-370) is a reissue of a previous program (PAR-23-295), indicating it is a recurring grant program. It is part of a larger series of ELSI funding opportunities offered by the NIH, which also includes R21 (Exploratory/Developmental) and R01 (Research Project) mechanisms for different project scopes and durations.

Funding

Up to 50000.00 USD

Deadline

Nov. 16, 2026, 10 p.m.

Details

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)

PAR-23-158

Programme: National Institutes of Health (NIH)

This grant, known as the 'Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required),' aims to fund exploratory and developmental clinical research that investigates the neurobiological mechanisms underlying Substance Use Disorders (SUDs). This includes fundamental brain circuitry and behavior related to substance use. It specifically targets basic science experimental studies involving human participants that fit the NIH definition of both a clinical trial and basic research. This funding opportunity is SECTOR-SPECIFIC, focusing on neuroscience, particularly within the context of addiction and substance use disorders. It is open to a broad range of organizational types, including research institutions, non-profits, and even for-profit entities, in the U.S. and internationally. It is a recurring grant opportunity with multiple application cycles through March 2026.

Funding

Up to 500000.00 USD